Back to results
US 2026/0306483 A1Published application
Pharmaceutical composition for keratosis and use thereof
AssigneeTanabe Pharma Corporation
InventorsRyuta SAITO, Yasuaki MATSUSHITA
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition for keratosis contains 5-methyl-2-(1-piperazinyl)benzenesulfonic acid. The compound may be in a form of an anhydrate thereof, a salt thereof, a hydrate or solvate thereof, or a hydrate or solvate of a salt thereof, and the hydrate is, for example, 5-methyl-2-(1-piperazinyl)benzenesulfonic acid monohydrate. The keratosis is, for example, Darier's disease or psoriasis.
Claims20
A method for treating acantholysis, comprising:
- administering an effective amount of a pharmaceutical composition comprising 5-methyl-2-(1-piperazinyl)benzenesulfonic acid to a subject in need thereof.
Dependencies are inferred from the claim text.